Literature DB >> 27349691

Preparation of osthole-loaded nano-vesicles for skin delivery: Characterization, in vitro skin permeation and preliminary in vivo pharmacokinetic studies.

Shu Meng1, Chong Zhang2, Wei Shi3, Xiao-Wei Zhang2, Dan-Hua Liu2, Ping Wang2, Jian-Xin Li2, Ying Jin2.   

Abstract

The main objective of the present research was to evaluate the flexible nano-vesicles for transdermal delivery of osthole. The nano-vesicles were formulated, characterized and evaluated for their physicochemical properties, in vitro skin permeation and in vivo plasma concentration. The encapsulation efficiency of osthole in ethosome and transfersome was measured to be 83.3±4.8% and 80.9±3.6%, respectively. In vitro studies showed that osthole ethosome provided an enhanced transdermal flux of 6.98±1.6μg/cm(2)/h and a decreased lag time of 2.45h across porcine ear skin. Moreover, ethosome also showed increased skin deposition of the drug over transfersome (1.5-fold) and saturated solution of osthole in 35% ethanol (2.1-fold). Data from in vivo pharmacokinetic studies showed that AUC and Cmax of the osthole loaded-ethosome were remarkably increasing compared with the other formulations. Thus, osthole ethosome was considered as an effective delivery system for the drug.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ethosome; Osthole; Pharmacokinetics; Transfersome

Mesh:

Substances:

Year:  2016        PMID: 27349691     DOI: 10.1016/j.ejps.2016.04.033

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  2 in total

Review 1.  Transfersomes as versatile and flexible nano-vesicular carriers in skin cancer therapy: the state of the art.

Authors:  Shubhra Rai; Vikas Pandey; Gopal Rai
Journal:  Nano Rev Exp       Date:  2017-06-07

2.  Effect of Polymer Permeability and Solvent Removal Rate on In Situ Forming Implants: Drug Burst Release and Microstructure.

Authors:  Xiaowei Zhang; Liqun Yang; Chong Zhang; Danhua Liu; Shu Meng; Wei Zhang; Shengnan Meng
Journal:  Pharmaceutics       Date:  2019-10-10       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.